Document Detail


IGF-1 controls GLUT3 expression in muscle via the transcriptional factor Sp1.
MedLine Citation:
PMID:  17920708     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Glucose transporter 3 (GLUT3), while first found in human fetal muscle, is predominantly expressed in brain and neural tissue. By several independent techniques we have previously shown that GLUT3 is expressed in human skeletal muscle cells. The structure of the human GLUT3 gene has not been previously reported nor has there been any evaluation of the 5'-untranslated region (UTR). To this end, we have cloned and sequenced the human GLUT3 gene. Insulin-like growth factor-1 (IGF-1) increased endogenous Glut3 protein in cultured L6 myotubes, and similarly stimulated luciferase activity in a construct of the human GLUT3 5'-UTR linked to a luciferase reporter gene. Actinomycin D, an inhibitor of mRNA synthesis, prevented IGF-1 stimulation of Glut3 protein. Transfection of L6 cells with Sp1 increased Glut3 and augmented IGF-1 stimulation of Glut3 expression. Knockdown of Glut3 expression in cultured L6 muscle cells using small interference RNA (siRNA) specific for Glut3 significantly reduced myocyte glucose uptake. DNAse footprinting and gel shift assays showed Sp1 specifically bound to the human GLUT3 5'-UTR. Substitution mutants of the human GLUT3 5'-UTR luciferase construct indicated that only one of three Sp1 site clusters was involved in IGF-1 action. These data, using both a human GLUT3 5'-UTR construct and L6 cells' endogenous promoter, suggest that IGF-1 plays a role in maintaining muscle GLUT3 expression and basal glucose uptake via the transcriptional factor Sp1.
Authors:
John A Copland; Aaron W Pardini; Thomas G Wood; Deling Yin; Allan Green; Yvonne H Bodenburg; Randall J Urban; Charles A Stuart
Related Documents :
22470418 - Microrna expression analysis in the cellulosic biofuel crop switchgrass (panicum virgat...
7537848 - An sp1 binding site and the minimal promoter contribute to overexpression of the cytoke...
7608198 - The human medium chain acyl-coa dehydrogenase gene promoter consists of a complex arran...
10329728 - An n-terminal region of sp1 targets its proteasome-dependent degradation in vitro.
22295078 - The ζ toxin induces a set of protective responses and dormancy.
22634628 - Eye enucleation activates the transcription nuclear factor kappa-b in the rat superior ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2007-09-04
Journal Detail:
Title:  Biochimica et biophysica acta     Volume:  1769     ISSN:  0006-3002     ISO Abbreviation:  Biochim. Biophys. Acta     Publication Date:    2007 Nov-Dec
Date Detail:
Created Date:  2007-11-20     Completed Date:  2008-01-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0217513     Medline TA:  Biochim Biophys Acta     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  631-40     Citation Subset:  IM    
Affiliation:
The Mayo Clinic Cancer Center, Jacksonville, Florida, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
5' Untranslated Regions / metabolism
Base Sequence
Cells, Cultured
Gene Expression Regulation*
Glucose / metabolism
Glucose Transporter Type 3 / genetics*
Humans
Insulin-Like Growth Factor I / physiology*
Molecular Sequence Data
Muscles / metabolism*
RNA, Small Interfering / pharmacology
Sp1 Transcription Factor / physiology*
Transcription, Genetic
Up-Regulation
Grant Support
ID/Acronym/Agency:
1P60AG17231/AG/NIA NIH HHS; HD-36092/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/5' Untranslated Regions; 0/Glucose Transporter Type 3; 0/RNA, Small Interfering; 0/Sp1 Transcription Factor; 50-99-7/Glucose; 67763-96-6/Insulin-Like Growth Factor I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on prolactin and somatolactin r...
Next Document:  Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhance...